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Aim: Children exposed to parental smoking are at increased long-term risk of subclinical atheroscle-
rosis in adulthood. However, it has not been quantified if exposure to parental smoking in childhood 
is associated with adult systemic inflammation. This study aimed to determine if childhood exposure 
to parental smoking was associated with high-sensitivity C-reactive protein (hsCRP) in adulthood. 
Methods: This longitudinal analysis of 2,511 participants used data from the Cardiovascular Risk in 
Young Finns Study, a prospective cohort of Finnish children. In 1980 or 1983, parents self-reported 
their smoking status and serum hsCRP was collected up to 31 years later in adulthood. 
Results: Compared with children with non-smoking parents, the relative risk of developing high 
hsCRP ( > 3 mg/L) in adulthood increased among those with 1 or both parents who smoked [ relative 
risk (RR), 1.3; 95%confidence interval (CI), 1.0-1.8] after adjustment for socioeconomic status, 
cardiovascular risk factors, and smoking status in childhood and adulthood. Moreover, children 
exposed to mother smoking [RR, 2.4; 95% Cl, 1.3-4.2] had highest risk of developing high hsCRP 
in adulthood compared with those exposed to father smoking [RR, 1.6; 95% Cl, 1.2-2.3] and both 
parents smoking [RR, 1.4; 95% Cl, 0.9-2.0]. 
Conclusion: Our findings suggest that children exposed to parental smoking are at increased risk of 
having high hsCRP in adulthood. Limiting children's exposure to passive smoking may have long-
term benefits on general low-grade inflammation. 
See editorial vol 24: 1204-1205 
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Introduction 
Exposure to environmental tobacco smoke (pas-
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sive smoking) is a major modifiable risk factor for car-
diovascular health 1-4J_ Children appear particularly vul-
nerable to increased exposure to passive smoking and 
acute and long-term health burdens from exposure to 
passive smoking5-7l. For example, studies have shown 
that exposure to parental smoking in utero or in child-
hood is associated with poorer markers of vascular 
structure and function in childhood and adulthood, 
indicating advanced preclinical atherosclerosis 8-15l . 
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Furthermore, parents who smoked but did so hygieni-
cally (i.e. did not smoke in the vicinity of their child) 
could decrease their child's risk of developing athero-
sclerosis in young to middle adulthood 12). 
Low-grade inflammation, characterized by only 
minor high-sensitivity C-reactive protein (hsCRP) ele-
vation, is considered one potential patho-physiological 
mechanism by which exposure to smoking might 
increase risk for coronary artery disease, endothelial 
dysfunction, and atherosclerotic plaque formation 16· 17). 
Studies in adults have indicated that active smoking 
increases coronary artery disease risk possibly due to a 
significant increase of low-grade inflammation 18-20l. 
Epidemiological studies in adults have observed a 
direct association between exposure to passive smok-
ing and low-grade inflammation, while the implemen-
tation of smoke-free legislation was shown to result in 
significant reduction of hsCRP and other inflamma-
tory markers 21-23l . However, it has not been quantified 
if exposure to parental smoking in childhood is associ-
ated with low-grade inflammation related to athero-
sclerosis in their adult offspring. 
Therefore, to better understand the long-term 
influence of exposure to parental smoking in child-
hood on later cardiovascular health, we aimed to 
determine if parental smoking in childhood was asso-
ciated with hsCRP in adult offspring. To examine this 
aim, we used data from the Cardiovascular Risk in 
Young Finns Study - a prospective cohort of a repre-
sentative sample of Finnish children that began in 
1980 and who have up to 31 years of follow-up 24l. 
Participants and Methods 
Participants 
Participants were from the Cardiovascular Risk 
in Young Finns Study, an ongoing population-based 
prospective cohort study designed to investigate the 
early-life risk factors of cardiovascular disease among 
children and young adults in Finland. In 1980, a total 
of 3,596 participants aged 3, 6, 9, 12, 15, and 18 
years attended the first cross-sectional (baseline) sur-
vey, and of these, 2,991 attended the 3-year follow-up 
performed in 1983. Adult clinic follow-ups were per-
formed in 2001, 2007, and 2011 when a total of 
2,284, 2,204, and 2,063 participants attended (refer 
to Supplemental Fig. I). In this study, we excluded 
those participants with hsCRP levels more than 10 
mg/L, chronic rheumatic disease, history of infection 
in the previous two weeks, type 1 diabetes, pregnant 
women, lactating women, and those women currently 
using oral contraceptives in 2011 (total n =315), 
2007(total n=408) and 2001(total n=588), as we 
have shown these factors to influence hsCRP levels25l . 
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However, to maximize our sample size, we used the 
adult hsCRP level from the most recent available from 
the 2001 , 2007, or 2011 adult follow-ups. For exam-
ple, data from 2007 or 2001 was used if it was missing 
in 2011. This was also the case for those who met our 
exclusion criteria on one occasion but not another. 
Because of this approach, we had data from up to 
2,511 participants for our analyses. Other covariates 
in adulthood were generated in the same way. Local 
ethics committees approved the study and all partici-
pants or their parents provided written informed con-
sent. Full details of the Cardiovascular Risk in Young 
Finns Study have been described elsewhere24l . 
Measures 
Exposure Measures 
At 1980 and 1983, parental smoking status was 
self-reported by parents as part of a questionnaire that 
was sent to the participant's home. Parents were asked 
whether the mother or father had ever smoked daily 
for at least I year (responses could be "yes" or "no"). 
Accordingly, "regular smoker" was designated to those 
whom ever smoked daily for at least 1 year. Families 
were further classified into "none" or "1 or both par-
ents smoking" 12l. In general, we used parental smok-
ing status data from 1980. Where these data were 
missing in 1980, data from 1983 was used. 
Clinic Characteristics and Risk Factors 
At baseline and adult follow-ups, height and 
weight were measured and body mass index (BMI) 
calculated as weight in kilograms divided by height in 
meters squared. There were two different kinds of 
physical activity questionnaires for the younger (3-6 
years old) and older (9- 18 years old) children. The 
calculated physical activity indices were age-standard-
ized to allow comparison across age groups26l . At base-
line, parents of participants self-reported total fruit 
and vegetable consumption of their child. Participants 
aged 12-18 years in 1980 reported their own smok-
ing status without their parents present (for the pur-
pose of our analyses, we assumed children aged < 12 
years were non-smokers). At adult follow-ups, ques-
tionnaires gathered data on participant's own active 
and passive smoking status. In childhood, parents' total 
years of schooling was considered an indicator of 
socio-economic status, whereas in adulthood, the par-
ticipant's total years of schooling was used in the anal-
yses 26l. Blood pressure was measured at baseline from 
the brachia! artery using a standard mercury sphygmo-
manometer for those aged 6 years and older, and using 
an ultrasound device for those aged 3 years. Blood 
pressure for the adult follow-ups was measured using a 
random-zero sphygmomanometer. At baseline and 
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follow-ups, serum total cholesterol, triglyceride and 
high-density lipoprotein (HDL)-cholesterol concen-
trations were determined using standard enzymatic 
methods and corrected for changes in methods and 
reagents across study years. Low-density lipoprotein 
(LDL)-cholesterol was calculated using the Friedewald 
equation. Full details of serum lipids have been pub-
lished previously27l. Childhood serum samples were 
taken in 1980 and stored at - 20 °C. During the stor-
age, the samples were not thawed or refrozen. Child-
hood hsCRP level in 1980 was assayed from stored 
serum samples that were analyzed in 2005, with values 
shown to be stable despite storage25l . 
Outcome Measures 
hsCRP levels were determined on an automated 
analyzer (Olympus AU400) using a turbidimetric immu-
noassay kit (1980 and 2001, CRP-UL reagent, detec-
tion limit= 0.02 mg/L, interassay CV< 5%; 2007 and 
2011, CRP Latex reagent) 25• 27l. In this study, partici-
pant's adult hsCRP status was categorized as either 
low ( ~ 3 mg/L) or high ( > 3 mg/L) based on recom-
mendations issued by the American Heart Association 
and a number of published papers28-32l. 
Statistical Analyses 
Continuous variables were displayed as mean 
(SD) or, if skewed distributions, as median (25th-75th 
percentiles), and categorical variables as proportions. 
Comparisons of baseline and adult characteristics 
according to the adult hsCRP status ( ~ 3 vs. > 3 mg/L) 
were examined using t-tests or One-way ANOVA. 
The association between childhood exposure to paren-
tal smoking and serum hsCRP in adulthood was 
examined using multivariable log binomial regression 
adjusting for a series of potential confounders and 
mediators. Model 1 adjusted for child age and sex. 
Model 2 additionally adjusted for child BMI, physical 
activity index, fruit and vegetable consumption, and 
parental school years. Model 3 additionally adjusted 
for child risk factors (systolic blood pressure, serum 
lipids). Model 4 additionally adjusted for adult BMI, 
own smoking, school years. Model 5 additionally 
adjusted for adult risk factors (systolic blood pressure, 
serum lipids). As a separate analysis to determine if 
the effect of maternal vs. paternal smoking on off-
spring hsCRP differed, we stratified our exposure into 
none vs. maternal only vs. paternal only vs. both par-
ents smoking. All models adjusted for the covariates 
listed for model 5 (above), but the sample size was 
somewhat reduced owing to restriction to two-parent 
families (n=2010). To supplement the dichotomous 
hsCRP outcome, we also repeated the above models 
using continuous hsCRP in adulthood as the out-
come. Continuous hsCRP in adulthood was log-trans-
formed because of a right-skewed distribution. The 
association between childhood exposure to parental 
smoking and log-hsCRP in adulthood was examined 
using multivariable linear regression. In sensitivity 
analyses, we further adjusted for child hsCRP. This 
was not included in the above models as only a 
reduced sample size (n = 2060/2511) had child hsCRP 
data available. We also performed a sensitivity analysis 
that additionally adjusted for adult exposure to passive 
smoking. Self report exposure to passive smoking in 
the home, workplace, and elsewhere was collected in 
2001, 2007, and 2011. Where data on adult exposure 
to passive smoking were missing, we assumed these 
participants were not passive smoking. The proportion 
of participants exposed to passive smoking in adult-
hood was 6.9% (n=174/2511). As we observed no 
significant multiplicative sex* or age*exposure inter-
actions, the data were not stratified by these covari-
ates. Statistical analyses were performed with STATA 
version 13 (Stata Corp, TX). All probability values 
were two-tailed and all confidence intervals were esti-
mated at the 95% level. 
Results 
Child and adult characteristics of participants 
according to adult hsCRP status are shown in Table 1. 
High hsCRP(>3 mg/L) was present in 271 (10.9%) 
participants. There were age and sex differences between 
hsCRP groups with the low hsCRP group younger on 
average and less likely to be females than those with 
high hsCRP levels. 
Risk of high hsCRP in offspring according to 
parental smoking is shown in Table 2. Compared with 
those with non-smoking parents, exposure to parental 
smoking in childhood was associated with an increased 
risk of high hsCRP in adulthood when adjusted for 
age and sex [relative risk (RR), 1.5; 95% confidence 
interval (CI), 1.2-2.0]. After adjustment for cardio-
vascular risk factors and participants' own smoking 
status in both childhood and adulthood, the risk of 
developing high hsCRP in adulthood reduced but 
remained statistically significant [RR, 1.3; 95% CI, 
1.0-1.8]. Parental smoking in childhood was associ-
ated with higher levels of adult hsCRP when exam-
ined as a continuous outcome (Table I in the online-
only supplement). But the effect was attenuated after 
adjustment for cardiovascular risk factors in adulthood 
(model 4 and 5). 
Because we observed a significant interaction 
(P= 0.002) between mother vs. father smoking, risks 
of high hsCRP in offspring stratified by exposure to 
mother or father smoking are displayed in Fig. 1. After 
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Table 1. Baseline and adult characteristics of participants according to circulating hsCRP level in adulthood (n = 2,511) 
AdulthsCRP 
Low (::;; 3 mg/L) High ( > 3 mg/L) 
Pvalue (n=l,238) (n=273) 
Baseline 
Female sex, % 49 60 0.001 
Age,y 10.6 (5.0) 11.4 (5.1) 0.013 
Parental school years, y * 9 (8, 11.5) 9 (8, 10.5) 0.006 
Smoking prevalence, % 1 6.2 8.0 0.258 
BMI, kg/m2 17.8 (2.9) 19.0 (3.8) <0.001 
Systolic BP, mm Hg 112 (12) 115 (13) <0.001 
HD L cholesterol, mmol/L 1.56 (0.31) 1.54 (0.31) 0.329 
LDL cholesterol, mmol/L 3.45 (0.82) 3.40 (0.78) 0.322 
TG, mmol/L 0.59 (0.45, 0.79) 0.64 (0.47, 0.89) 0.007 
hsCRP, mg/L 0.21 (0.11 ,0.52) 0.44 (0.2, 0.84) <0.001 
Fruit consumption, frequency/wk# 6.3 (6.3, 9.5) 6.3 (6.3, 9.5) 0.327 
Vegetable consumption, frequency/wk# 6.3 (3.0, 9.5) 6.3 (3.0, 9.5) 0.037 
standardized PAI* 0.02 (1.01) - 0.05 (0.94) 0.326 
Adulthood 
Age,y 41.6 (5.0) 42.4 (5.1) 0.013 
Own school years, y * 15 (12, 17) 14 (12, 17) 0.007 
Own smoking prevalence, % 19 22 0.159 
Passive smoking prevalence, % 7 9 0.194 
BMI, kg/m2 25.8 (4.3) 31.1 (6.6) <0.001 
Systolic BP, mm Hg 119 (14) 124 (15) <0.001 
HDL cholesterol, mmol/L 1.32 (0.32) 1.22 (0.31) <0.001 
LDL cholesterol, mmol/L 3.27 (0.83) 3.29 (0.84) 0.770 
TG, mmol/L 1.05 (0.75, 1.5) 1.36 (0.95, 1.9) <0.001 
Data are mean (SD) or median (25th, 75th percentile) for continuous variables and percentages for categorical variables. Participants with hsCRP 
levels > 10 mg/L, type 1 diabetes, chronic rheumatic disease, history of recent infection, and pregnant women, lactating women, and those using 
oral contraceptives were excluded from the analysis. Abbreviations: confidence interval, Cl; high-sensitivity C-reactive protein, hsCRP; body mass 
index, BMI; physical activity index, PAI; blood pressure, BP; high-density lipoprotein, HDL; low-density lipoprotein, LDL; triglycerides, TG. 
*In childhood, parent school years was considered an indicator of socioeconomic status. In adulthood, the participant's own school years was used. 
1 Data on childhood smoking status was collected only on those aged12 to 18 years in 1980, to maintain the sample size for these analyses, we 
assigned all children aged 3 to 9 years as nonsmokers. 
*There were two different physical activity questionnaires used for younger (3-6 years old) and older (9-18 years old) children. The calculated phys-
ical activity indices were age-standardized co allow comparison across age groups. 
#When examined as mean (SD), fruit consumption [6.87 (2.79) vs. 6.66 (2.93), Pvalue=0.254] and vegetable consumption [6.33 (2.83) vs. 5.90 
(3.05), Pvalue=0.021] by low vs. high hsCRP levels. 
adjustment for potential confounding and mediating 
factors, the effect of having high hsCRP levels as 
adults was strongest for exposure to mother only 
smoking in childhood [RR, 2.4; 95% CI, 1.3-4.2], 
followed by father only smoking [RR, 1.6; 95% CI, 
1.2-2.3], and both parents smoking [RR, 1.4; 95% 
CI, 0.9-2.0]. When hsCRP was examined as a con-
tinuous outcome, we again observed the strongest 
effect for mother only smoking [/3, 0.22 mg/L; 95% 
CI, 0.03-0.42] compared with father only smoking 
[/3, 0.08 mg/L; 95% CI, -0.02-0.18] and both par-
ents smoking [/3, 0.07 mg/L; 95% CI, -0.04-0.19]. 
In sensitivity analyses, we further adjusted with 
1234 
child hsCRP and adult exposure to passive smoking in 
addition to the covariates included in model 5 (Table 
2). Child hsCRP was not included as a covariate in 
our models as a number of participants were missing 
these data (n = 451 for child hsCRP). Nevertheless, the 
risks of developing high hsCRP in adulthood remained 
essentially similar in this reduced sample to the esti-
mates shown in Table 2 for the full sample [RR, 1.4; 
95% CI, 1.0-1.9; and 1.3; 95% CI, 1.0-1.8]. Adjust-
ment for adult physical activity did not modify the 
observed effect for model 5 in Table 2 (effect of paren-
tal smoking on high hsCRP was RR= 1.3, 95%CI = 
1.0-1.8 when adult physical activity was included vs. 
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Table 2. Relative risk (RR) and 95% confidence interval (CI) of high hsCRP in adult offspring according to 
parental smoking status in offspring's childhood. 
Models 
1 =adjusted with child age, sex (n=2,51 l) 
2=model 1 plus child BMI, own smoking, PAI, parental 
school years, fruit and vegetable consumption 
(n=2,369) 
3=model 2 plus child systolic BP, HDL, LDL, TG 
(n=2,344) 
4=model 3 plus adult BMI, adult own smoking, adult 
own school years (n=2,314) 
5 = model 4 plus adult systolic BP, HDL, LDL, TG 
(n=2,295) 
See Table 1 footnote for abbreviations. 
RR= 1.3, 95%CI= 1.0-1.8 when adult physical activ-
ity was not included). 
Discussion 
In this study, we found that offspring exposed to 
parental smoking in childhood or adolescence had a 
greater risk of high hsCRP in adulthood compared 
with those with non-smoking parents. Elevated hsCRP 
is associated with an increased risk of atherosclerosis 
and coronary events in patients with CVD as well as 
in healthy adults 3°, 31, 33l. The American Heart Associa-
tion recommends that hsCRP is a marker for athero-
sclerosis, with the measurement of hsCRP in adults 
used as an adjunct to other established risk factors to 
predict cardiovascular risk28l. These data add further 
evidence that exposure to parental smoking early in 
life has a long-term impact on cardiovascular health in 
adulthood; consistent with our previous findings 
regarding parental smoking in childhood with impaired 
adult endothelial function, increased carotid artery 
intima-media thickness, and presence of atheroscle-
rotic plaque9' 11• 12l. 
In this study, we observed a stronger risk for high 
hsCRP among adult offspring for those exposed to 
maternal smoking compared with those exposed to 
paternal smoking. Similarly, in terms of other cardio-
vascular risk factors, it has been reported that there was 
a stronger effect for maternal vs. paternal smoking on 
metabolic syndrome, waist circumference, and carotid 
artery intima-media thickness in offspring8• 34l. Also, 
we previously observed stronger risk for developing ath-
erosclerotic plaque in adult offspring for those exposed 
to maternal compared with paternal smoking 12l. The 
Parental Regular Smoking (None vs. 1 or Both) 
RR 95% CI Pvalue 
1.5 1.2, 2.0 0.002 
1.4 1.0, 1.8 0.025 
1.4 1.0, 1.9 0.019 
1.3 1.0, 1.8 0.033 
1.3 1.0, 1.8 O.D35 
stronger effect for maternal smoking might be explained 
by the fact that mothers spend, on average, more time 
around the child compared with fathers, thus off-
spring could reasonably have more exposure to mater-
nal smoking. This assumption, however, presumes the 
effects of passive smoking are direct, i.e. due to the 
cells exposure to the chemicals in tobacco smoke. An 
alternative explanation is that these effects are indirect 
due to epigenetic inheritance. For example, a trans-
generational influence of prenatal cigarette smoking 
by the grandmother on the grandchild's respiratory 
health and anthropometry has been reported 35• 36l. As 
there were no substantial differences in baseline char-
acteristics between groups, it is unclear as to the under-
lying reason for why we observed a stronger effect for 
mother only smoking compared with both parents 
smoking. The difference may be related to unmea-
sured sociodemographic factors or differences in smok-
ing hygiene between the groups. 
The link between exposure to tobacco smoke, 
both active and passive, in adults and low-grade sys-
temic inflammation related to coronary artery disease 
has previously been reported. The Emerging Risk Fac-
tors Collaboration reported that hsCRP levels were 
37% (95% Cl, 31-44%) higher in adult smokers 
compared with non-smokers 20l. The Multi-Ethnic 
Study of Atherosclerosis found that the risk of high 
hsCRP was almost two-fold higher for smokers (odds 
ratio, 1.7; 95% CI, 1.5-2.1) compared with non-
smokers in adults 37l. It has been shown that systemic 
inflammation induced by passive smoking is nearly as 
substantial as those from long-term active smoking in 
adults. For example, Panagiotakos et al. observed that 
higher hsCRP levels (0.08 mg/dL; P=0.03) and higher 
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Exposure 
Only Mother Smoking 
Only Father Smoking 
Both Parents Smoking 
No parental Smoking 
I 
0.5 
I 
I 
I 
I 
I 
? 
1.0 
I 
1.5 
I 
2.0 
Relative Risk (95% Cl) 
2.4 (1.3, 4.2) 
1.6 (1.2, 2.3) 
1.4 (0.9, 2.0) 
I I 
3.0 5.0 
Relative Risk of High hsCRP 
Fig. I. Relative risks and 95% confidence intervals (CI) of high hsCRP in adult offspring stratified 
by parent smoking status in the offspring's childhood. 
white blood cell counts among adults who self-reported 
exposure to passive smoking more than three days per 
week compared with those not exposed to secondhand 
smoke21J. Data from cross-sectional and longitudinal 
studies that used more objective markers of passive 
smoke exposure (salivary cotinine) provided further 
confirmation of the Panagiocakos et al. study22• 38l. In 
contrast, cross-sectional studies using objectively mea-
sured exposure by serum cotinine showed passive 
smoking in adults was not associated with CRP or 
white blood cell counts. However, the authors pointed 
out chis might be because the study did not use high-
sensitivity laboratory methods for CRP23• 39l . The data 
reported in our study are the first linking childhood 
exposure to passive smoking with adult hsCRP levels. 
Tobacco smoke promotes atherosclerosis, mainly 
through a disorder of cholesterol proteins, accelerating 
lipid peroxidation, as well as platelet aggregation and 
clotting, leading to endothelial dysfunction. Moreover, 
tobacco smoke exposure in adults, both active and 
passive, enhances the low-grade systemic inflamma-
tion related to atherosclerosis. In this study, we adjusted 
for several conventional cardiovascular risk factors as 
potential mediating factors, such as child and adult 
BMI, systolic blood pressure, HDL-cholesterol, LDL-
cholesterol, triglycerides, but also included child and 
adult own smoking status as potential confounding 
1236 
factors. Further adjustment of our models for child 
hsCRP did not modify the associations, suggesting 
chat parental smoking might act on later risk of high 
hsCRP through other mechanisms than tracking of 
hsCRP from childhood to adulthood 25l. 
Normally, acute inflammation induced by trau-
matic injury or infection leads to a marked release of 
CRP into the circulation, while only minor CRP ele-
vation (concentrations between 3 and 10 mg/L) has 
been generally regarded as a marker of low-grade 
inflammation related to chronic inflammatory envi-
ronment due to autoimmune diseases and metabolic 
disorders, such as rheumatic disease, diabetes, hyper-
tension and obesity. In early stage atherosclerosis fol-
lowing exposure to risk factors such as tobacco smoke, 
circulating inflammatory and immune cells migrate to 
the developing lesion in response to lipid peroxidation. 
Here they interact with the arterial wall and release 
pro-inflammatory cytokines, interleukin-I, tumor necro-
sis factor, that further induce release of interleukin-6 
into the circulation. lnterleukin-6, in turn, stimulates 
the production of large amounts of acute-phase reac-
tants such as CRP, especially in the liver and is released 
into circulation 16• 17). 
It has previously been reported chat stricter pub-
lic smoking restrictions might have displaced smokers 
into the home, resulting in increased passive smoking 
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exposure to their children 4o). Although the fetal and 
neonatal effects of parental smoking in offspring have 
been recognized, particularly for respiratory health 
and normal growth and development, our findings 
highlight the importance of reducing passive smoke 
exposure on children and adolescents in an effort to 
improve long-term cardiovascular health in adulthood. 
In this study, our data suggest that those children and 
adolescents exposed to passive smoking at home are 
more likely to have low-grade, systemic inflammation 
than their counterparts who were not exposed. Given 
minor CRP elevation was reported with increased risk 
of atherosclerosis, ischemic stroke, overweight/obesity 
and lipid disorders41-43l, limiting children's exposure to 
passive smoking may have long-term benefits on later 
cardiovascular health. Future research should deter-
mine the utility of retrospective reports of parent 
smoking to cardiovascular risk screening. 
This study had limitations. Although it has been 
shown that intrauterine exposure to maternal and 
paternal tobacco smoke has a long-term influence on 
the offspring's cardiovascular health 44, 45l, data on 
parental smoking during pregnancy was not measured 
in this study. As such, it is possible that exposure to 
parental smoking in childhood is a marker of those 
exposed to passive smoking in utero and it may be this 
exposure that impacts on systemic inflammation. 
Another limitation concerns residual confounding that 
may have resulted from storage of child hsCRP for 25 
years before measurement. However, the samples were 
not thawed or refrozen during storage and we have 
previously shown high agreement between hsCRP lev-
els from the same participants measured at the time of 
blood sampling and after storage for 5 years 25l. A fur-
ther limitation is the reliance on a self-report exposure 
measure. However, in a subset of participants in this 
study we have shown that participants were signifi-
cantly less likely to have no detectable serum cotinine 
as the level of reported parental smoking increased 12l . 
Additionally, the lack of follow-up data on anti-
inflammatory medication, such as non-steroidal anti-
inflammatory drugs and steroids, is a limitation. Finally, 
differential loss to follow-up of the initial representa-
tive cohort is possible. However, we have previously 
found participants are largely representative of the 
original sample24l. The major strengths of this study 
include the very long-term follow-up with exposure 
measurements in childhood, measures of important 
potential confounders and mediators, and outcome 
data from a follow-up of over 30 years. Moreover, we 
were able to adjust for child hsCRP levels to deter-
mine the independent association of our exposure, 
which is unique to child to adult cohorts of this age 
and length to follow-up. 
Conclusion 
Exposure to parental smoking in childhood has a 
long-term association with risk of high hsCRP in adult-
hood. Limiting children's exposure to passive smoking 
may have long-term benefits on general low-grade 
inflammation. 
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Parental Smoking and Systemic Inflammation in Adult Offspring 
Supplemental Table 2. Baseline and adult characteristics of participants according to exposure to parental regular smoking in 
childhood (n = 2,511) 
Parental smoking (None vs. 1 or Both) 
None 1 or Both 
Pvalue (n=768) (n=l,743) 
Baseline 
Female sex, % 51 50 0.757 
Age,y 10.9 (5.2) 10.6 (4.9) 0.182 
Parental school years, y * 9 (8, 12) 9 (8, 11) 0.037 
Smoking prevalence, % t 6.3 6.4 0.941 
BMI, kg/m2 17.8 (3.0) 17.9 (3.1) 0.408 
Systolic BP, mm Hg 113 (12) 113 (12) 0.169 
HDL cholesterol, mmol/L 1.56 (0.30) 1.56 (0.31) 0.767 
LDL cholesterol, mmol/L 3.49 (0.83) 3.42 (0.81) 0.083 
TG, mmol/L 0.61 (0.46, 0.80) 0.59 (0.45, 0.79) 0.262 
hsCRP, mg/L 0.20 (0.11, 0.48) 0.23 (0.11, 0.61) 0.115 
Fruit consumption, frequency/wk~ 6.3 (6.3, 9.5) 6.3 (6.3, 9.5) 0.016 
Vegetable consumption, frequency/wk~ 6.3 (6.3, 9.5) 6.3 (3.0, 9.5) <0.001 
standardized PAI* 0.002 (1.019) O.Dl5 (0.997) 0.768 
Adulthood 
Age,y 41.9 (5.2) 41.6 (4.9) 0.182 
Own school years, y * 16 (13, 18) 15 (12, 17) <0.001 
Own smoking prevalence, % 12.4 21.9 <0.001 
Passive smoking prevalence, % 5.2 7.7 0.024 
BMI, kg/m2 25.9 (4.8) 26.5 (5.0) 0.006 
Systolic BP, mm Hg 120 (14) 120 (14) 0.938 
HDL cholesterol, mmol/L 1.31 (0.33) 1.31 (0.32) 0.937 
LDL cholesterol, mmol/L 3.33 (0.86) 3.25 (0.82) 0.046 
TG, mmol/L 1.05 (0.75, 1.56) 1.05 (0.75, 1.56) 0.445 
hsCRP, mg/L 0.67 (0.31, 1.42) 0.77 (0.34, 1.72) 0.002 
Data are mean (SD) or median (25th, 75th percentile) for continuous variables and percentages for categorical variables. 
Abbreviations: confidence interval, Cl; high-sensitivity C-reactive protein, hsCRP; body mass index, BMI; physical activity index, PAI; blood pres-
sure, BP; high-density lipoprotein, HDL; low-density lipoprotein, LDL; triglycerides, TG. 
*In childhood, parent school years was considered an indicator of socioeconomic status. In adulthood, the participant's own school years was used. 
t Data on childhood smoking status was collected only on those aged12 to 18 years in 1980, to maintain the sample size for these analyses, we 
assigned all children aged 3 to 9 years as nonsmokers. 
*There were two different physical activity questionnaires used for younger (3-6 years old) and older (9-18 years old) children. The calculated phys-
ical activity indices were age-standardized to allow comparison across age groups. 
~When examined as mean (SD), fruit consumption [7.05 (2.74) vs. 6.76 (2.84), P value=0.016] and vegetable consumption [6.60 (2.78) vs. 6.14 
(2.88), Pvalue < 0.001] by low vs. high hsCRP levels. 
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